Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Teresa H EveringKara W ChewMark J GigantiCarlee B MoserMauricio PinillaDavid Alain WohlJudith S CurrierJoseph J EronArzhang Cyrus JavanRachel Bender IgnacioDavid MargolisQing ZhuJi MaLijie ZhongLi YanUlises D'Andrea NoresKeila HooverBharat MocherlaManish Chandra ChoudharyRinki DeoJustin RitzWilliam A FischerCourtney V FletcherJonathan Z LiMichael D HughesDavey M SmithEric S Daarnull nullPublished in: Annals of internal medicine (2023)
National Institute of Allergy and Infectious Diseases of the National Institutes of Health.